ArticleKidney3602026
Phenotyping of Heart Failure in CKD Using Electrocardiography Features.
Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electrocardiogram Markers of Incident Heart Failure in CKD.Kidney360 · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
key pointsElectrocardiography features have incremental value in prediction of heart failure in CKD beyond clinical features. Comparison and integration in existing risk scores is needed.
backgroundTools for predicting heart failure in patients with CKD remain limited. We aimed to study whether standard electrocardiography (ECG) features or heart rate variability parameters predict de novo heart failure hospitalization in individuals with CKD.
methodsUsing a large New York University ECG database linked with electronic health records (2012-2021), we analyzed a cohort of patients with preexisting CKD. Besides standard ECG features, we extracted heart rate variability (measures the time between consecutive heart beats in milliseconds) features from the ECGs as predictors. The index ECG was the first ECG performed after the index eGFR date (baseline) and was required to be performed before initiation of dialysis, ESKD, or transplant. The primary outcome was time to index heart failure hospitalization (≥30 days after the index ECG) on the basis of discharge International Classification of Diseases, Tenth Revision codes. Least absolute shrinkage and selection operator-penalized Cox regression was used to identify predictors. Sensitivity analyses used Fine-Gray competing risk models for death and ESKD.
resultsAmong 11,409 individuals (median age: 72 years; approximately 50% men) with a median of 976 days, 880 individuals (8%) experienced an index heart failure hospitalization. Models incorporating ECG and clinical parameters had excellent discrimination ( C -statistic 0.76 in the training set and 0.73 in the validation set). Among ECG features, the PR interval, corrected QT, and T axis were independently associated with higher risks of index heart failure hospitalization ≥30 days after the index ECG in both primary models ( P < 0.001 for all), and in models accounting for competing risks ( P < 0.01 for all). History of arrhythmia (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.36 to 1.88), valvular disease (HR, 1.51; 95% CI, 1.27 to 1.81), and diabetes (HR, 1.41; 95% CI, 1.22 to 1.65) were the strongest clinical predictors. Heart rate variability parameters were not independently associated with heart failure.
conclusionsAlthough ECG-derived heart rate variability indices were not independently associated with risk of heart failure, several standard ECG features are associated with heart failure hospitalization in patients with CKD. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2026_07_30_KID0000001175.mp3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.